CRIPTO and non-small cell lung carcinoma: Interestingly, Xu et colleagues showed in their clinical study that the incidence of distant metastasis for stage I NSCLC patients with high CRIPTO expression was significantly higher than that of patients with low CRIPTO expression [65].